Benzinga | Aug 4, 2020 06:41AM EDT

Epizyme Q2 EPS $(0.58) Beats $(0.61) Estimate, Sales $2.47M Miss $4.30M Estimate

Epizyme (NASDAQ:EPZM) reported quarterly losses of $(0.58) per share which beat the analyst consensus estimate of $(0.61) by 4.92 percent. This is a 9.43 percent decrease over losses of $(0.53) per share from the same period last year. The company reported quarterly sales of $2.47 million which missed the analyst consensus estimate of $4.30 million by 42.63 percent. This is a 58.19 percent decrease over sales of $5.90 million the same period last year.